Episurf Medical AB (publ) Strategic Asset Allocation Index
Episurf Medical AB (publ) strategic asset allocation index. Episurf Medical AB (publ) (EPIS-B) has a Strategic Asset Allocation Index of 10.7% as of December 2025. Strategic assets (PP&E of Skr5.10 Million plus long-term investments of Skr-) total Skr5.10 Million, measured against net assets of Skr47.50 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Episurf Medical AB (publ) (EPIS-B) tangible equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Episurf Medical AB (publ) (2013–2025)
Strategic asset allocation index of Episurf Medical AB (publ) from 2013 to 2025. This chart shows how Episurf Medical AB (publ)'s Strategic Asset Allocation Index has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the index stands at 10.7%, representing strategic assets of Skr5.10 Million against net assets of Skr47.50 Million SEK.
Episurf Medical AB (publ) Strategic Asset Allocation Index by Year (2013–2025)
Episurf Medical AB (publ) strategic asset allocation index by year from 2013 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Episurf Medical AB (publ) from 2013 to 2025, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see EPIS-B market cap overview.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 10.7% | Skr5.10 Million | Skr5.10 Million | Skr- | Skr47.50 Million | ▲ +7.4 pp |
| 2024 | 3.3% | Skr2.80 Million | Skr2.80 Million | Skr- | Skr83.80 Million | ▼ -3.3 pp |
| 2023 | 6.6% | Skr5.60 Million | Skr5.60 Million | Skr- | Skr84.50 Million | ▲ +2.9 pp |
| 2022 | 3.8% | Skr6.70 Million | Skr6.70 Million | Skr- | Skr177.70 Million | ▲ +2.5 pp |
| 2021 | 1.3% | Skr3.30 Million | Skr3.30 Million | Skr- | Skr252.80 Million | ▼ -0.9 pp |
| 2020 | 2.2% | Skr3.80 Million | Skr3.80 Million | Skr- | Skr169.50 Million | ▼ -12.3 pp |
| 2019 | 14.5% | Skr6.00 Million | Skr6.00 Million | Skr- | Skr41.40 Million | ▲ +14.3 pp |
| 2018 | 0.2% | Skr100.00K | Skr100.00K | Skr- | Skr44.80 Million | ▼ 0.0 pp |
| 2017 | 0.2% | Skr200.00K | Skr200.00K | Skr- | Skr85.57 Million | ▼ -0.6 pp |
| 2016 | 0.8% | Skr382.05K | Skr382.05K | Skr- | Skr48.70 Million | ▲ +0.4 pp |
| 2015 | 0.4% | Skr423.84K | Skr423.84K | Skr- | Skr109.93 Million | ▼ -0.7 pp |
| 2014 | 1.1% | Skr426.68K | Skr426.68K | Skr- | Skr38.85 Million | ▲ +0.4 pp |
| 2013 | 0.7% | Skr519.20K | Skr519.20K | Skr- | Skr71.61 Million | — |